Covington & Burling LLP and Gibson Dunn & Crutcher LLP have advised Merck & Co., Inc. Freshfields has advised Terns Pharmaceuticals, Inc. Merck & Co., Inc.,...
Merck to Acquire Terns Pharmaceuticals for $6.7 Billion
Novartis Acquires Avidity Biosciences in USD 12 Billion Transaction and Completes USD 11 Billion Financing
Covington and Homburger have advised Novartis. Kirkland & Ellis and Wilson Sonsini Goodrich & Rosati have advised Avidity Biosciences. Linklaters has advised a global underwriting syndicate....
Novartis to Acquire Avidity Biosciences for $12 Billion and Spin Out Precision Cardiology Programs
Covington has advised Novartis, Kirkland & Ellis has advised Avidity Biosciences. Novartis has announced its entry into a definitive merger agreement to acquire Avidity Biosciences, Inc.,...
AbbVie Acquires Gilgamesh’s Lead Antidepressant Program for Up to $1.2 Billion
Covington & Burling LLP has advised AbbVie, and Ropes & Gray LLP have advised Gilgamesh Pharmaceuticals. AbbVie has entered into a definitive agreement to acquire the...
Bristol Myers Squibb to Acquire Orbital Therapeutics in $1.5 Billion Agreement
Covington & Burling LLP has advised Bristol Myers Squibb, and Goodwin Proctor LLP has advised Orbital Therapeutics. Bristol Myers Squibb has entered into a definitive agreement...
Eaton Acquires Ultra PCS Limited for $1.55 Billion
Covington & Burling has advised Eaton on the transaction, while Weil has advised the Cobham Ultra Group. Eaton has entered into a definitive agreement to acquire...
Bristol Myers Squibb’s $286 Million Acquisition of 2seventy bio
Covington & Burling advised Bristol Myers Squibb on the deal, and Goodwin Procter advised 2seventy bio. Bristol Myers Squibb (NYSE: BMY) (“BMS”) announced its merger agreement...
Quanterix’s Acquisition of Akoya Biosciences
Covington & Burling represented Quanterix Corporation, and DLA Piper represented Akoya Biosciences in the transaction. Skadden represented Goldman Sachs & Co. LLC as financial advisor to...
AbbVie’s $1.4 Billion Acquisition of Aliada Therapeutics
Covington & Burling advised AbbVie on the transaction, and Fenwick & West advised Aliada Therapeutics. AbbVie (NYSE: ABBV), a pharmaceutical firm, announced it has entered into...
Merck’s $1.3 Billion Acquisition of Elanco’s Aqua Business
Covington & Burling is advising Merck Animal Health on the transaction, and White & Case is advising Elanco Animal Health Inc. Merck Animal Health (Merck)(NYSE: MRK) announced...
Bristol Myers Squibb’s $4.1 Billion Acquisition of RayzeBio
Covington advised Bristol Myers Squibb on the transaction, while Cooley and Wilson Sonsini Goodrich & Rosati advised RayzeBio Inc. Goodwin advised Centerview Partners in its role...